<DOC>
	<DOCNO>NCT00814515</DOCNO>
	<brief_summary>A Phase III , Multicenter , Randomized , Controlled , Double-Masked Trial NOVA22007 ( Ciclosporin 0.1 % ) Ophthalmic Cationic Emulsion versus Vehicle Patients Moderate Severe Dry Eye Syndrome</brief_summary>
	<brief_title>Double-Masked Trial NOVA22007 ( Ciclosporin 0.1 % ) Versus Vehicle Patients With Moderate Severe Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Males females 18 year age great . At baseline , moderate severe dry eye condition persist despite conventional management . Presence history systemic ocular disorder condition , include ocular surgery , trauma disease could possibly interfere interpretation study result . Any relevant ocular anomaly interfere ocular surface , include post radiation keratitis , StevensJohnson syndrome , corneal ulcer history concomitant corneal ulcer infectious origin , etc . Any ocular disease require topical ocular treatment study period . Patient participate clinical trial new active substance past month study entry . Participation another clinical study time present study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Moderate</keyword>
	<keyword>Severe</keyword>
	<keyword>Dry</keyword>
	<keyword>Eye</keyword>
	<keyword>Ciclosporin</keyword>
	<keyword>Cyclosporine</keyword>
</DOC>